Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Stage I Prostate Cancer
- Stage I Breast Cancer
- Stage I Colorectal Cancer AJCC v6 and v7
- Stage III Colorectal Cancer AJCC v7
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage IIIA Colorectal Cancer AJCC v7
- Stage IIB Colorectal Cancer AJCC v7
- Stage IIIB Colorectal Cancer AJCC v7
- Stage IIB Prostate Cancer
- Stage II Breast Cancer
- Stage IIB Breast Cancer
- Stage IIC Colorectal Cancer AJCC v7
- Stage II Colorectal Cancer AJCC v7
- Stage II Prostate Cancer
- Stage IIA Breast Cancer
- Stage IIA Colorectal Cancer AJCC v7
- Stage IIA Prostate Cancer
- Stage IIIC Colorectal Cancer AJCC v7
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 30 years and 125 years
- Gender
- Both males and females
Description
PRIMARY OBJECTIVES: I. Develop the EXCELS intervention to facilitate engaged self-management of cancer follow-up for cancer survivors. II. Evaluate the efficacy of EXCELS intervention in a small randomized controlled trial. III. Assess/refine intervention usability and acceptability for primary care...
PRIMARY OBJECTIVES: I. Develop the EXCELS intervention to facilitate engaged self-management of cancer follow-up for cancer survivors. II. Evaluate the efficacy of EXCELS intervention in a small randomized controlled trial. III. Assess/refine intervention usability and acceptability for primary care patients. OUTLINE: PHASE I: EXCELS intervention is developed and assessed. PHASE II: Participants are randomized into 1 of 4 arms. ARM I: Participants receive National Cancer Institute's Facing Forward brochure. ARM II: Participants have untimed access to the EXCELS mobile web application. ARM III: Participants also receive 4 calls of 15-20 minutes each over 3 months focusing on assisting survivors with addressing challenges to receiving preventive service and health care. ARM IV: Participants have access to EXCELS website as in Arm II. Participants also receive 4 health coaching calls as in Arm III. Patients are followed up at 6 months, 12 months and 18 months post randomization.
Tracking Information
- NCT #
- NCT03233555
- Collaborators
- National Cancer Institute (NCI)
- National Institutes of Health (NIH)
- Investigators
- Principal Investigator: Shawna Hudson Rutgers Cancer Institute of New Jersey
Get Well Soon